Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jul 22;3(3):1109-27.
doi: 10.3390/brainsci3031109.

Astrocyte regulation of CNS inflammation and remyelination

Affiliations

Astrocyte regulation of CNS inflammation and remyelination

Kumiko I Claycomb et al. Brain Sci. .

Abstract

Astrocytes regulate fundamentally important functions to maintain central nervous system (CNS) homeostasis. Altered astrocytic function is now recognized as a primary contributing factor to an increasing number of neurological diseases. In this review, we provide an overview of our rapidly developing understanding of the basal and inflammatory functions of astrocytes as mediators of CNS responsiveness to inflammation and injury. Specifically, we elaborate on ways that astrocytes actively participate in the pathogenesis of demyelinating diseases of the CNS through their immunomodulatory roles as CNS antigen presenting cells, modulators of blood brain barrier function and as a source of chemokines and cytokines. We also outline how changes in the extracellular matrix can modulate astrocytes phenotypically, resulting in dysregulation of astrocytic responses during inflammatory injury. We also relate recent studies describing newly identified roles for astrocytes in leukodystrophies. Finally, we describe recent advances in how adapting this increasing breadth of knowledge on astrocytes has fostered new ways of thinking about human diseases, which offer potential to modulate astrocytic heterogeneity and plasticity towards therapeutic gain. In summary, recent studies have provided improved insight in a wide variety of neuroinflammatory and demyelinating diseases, and future research on astrocyte pathophysiology is expected to provide new perspectives on these diseases, for which new treatment modalities are increasingly necessary.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Widespread astrogliosis is a prominent neuropathological feature of the twitcher mouse brain. Representative pictures show immunohistochemically labeled glial fibrillary acidic protein (GFAP)+ astrocytes (red) in several regions of the brain, including cerebellum, midbrain, thalamus, and cortex in wildtype C57BL/6 (upper row) and in age-matched twitcher mice (bottom row). Note that highly fibrous GFAP immunoreactivity is observed with greater intensity throughout the twitcher mouse brain, compared to wildtype mouse. Scare bar = 250 μm.

Similar articles

Cited by

References

    1. De Jager P.L., Hafler D.A. New therapeutic approaches for multiple sclerosis. Annu. Rev. Med. 2007;58:417–432. doi: 10.1146/annurev.med.58.071105.111552. - DOI - PubMed
    1. Runia T.F., van Pelt-Gravesteijn E.D., Hintzen R.Q. Recent gains in clinical multiple sclerosis research. CNS Neurol. Disord. Drug Targets. 2012;11:497–505. doi: 10.2174/187152712801661239. - DOI - PubMed
    1. Shirani A., Zhao Y., Karim M.E., Evans C., Kingwell E., van der Kop M.L., Oger J., Gustafson P., Petkau J., Tremlett H. Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis. JAMA. 2012;308:247–256. doi: 10.1001/jama.2012.7625. - DOI - PubMed
    1. Stys P.K., Zamponi G.W., van Minnen J., Geurts J.J. Will the real multiple sclerosis please stand up? Nat. Rev. Neurosci. 2012;13:507–514. - PubMed
    1. Trapp B.D., Nave K.A. Multiple sclerosis: An immune or neurodegenerative disorder? Annu. Rev. Neurosci. 2008;31:247–269. doi: 10.1146/annurev.neuro.30.051606.094313. - DOI - PubMed

LinkOut - more resources